The heavy selling pressure might have exhausted for James Hardie (JHX) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
James Hardie (JHX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
James Hardie is rated a BUY, as the market underestimates its structural shift toward repair & remodel and overstates cyclicality risks. JHX dominates the fiber cement siding market, benefits from material substitution trends, and is resilient due to pricing power and margin discipline. The AZEK acquisition doubles JHX's addressable market, offering cross-selling synergies and cost savings, positioning JHX as a premium exterior brand.
The mean of analysts' price targets for James Hardie (JHX) points to a 27.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
James Hardie Industries plc ( JHX ) Shareholder/Analyst Call October 29, 2025 4:00 PM EDT Company Participants Anne Lloyd Presentation Operator Good day, and welcome to the 2025 Annual General Meeting of James Hardie Industries plc. Please note that today's meeting is being recorded.
James Hardie Industries (NYSE:JHX) shares tumbled more than 35% on Wednesday, marking their steepest one-day drop since 1973, after the building materials company posted weaker-than-expected quarterly results and sharply cut its outlook for the year. The maker of fiber cement siding and other home construction products reported fiscal first quarter net income of $62.6 million, or $0.15 per share, down from $155.3 million, or $0.36 per share, a year earlier.
James Hardie Industries plc (NYSE:JHX ) Q1 2026 Earnings Conference Call August 19, 2025 6:00 PM ET Company Participants Aaron M. Erter - CEO & Executive Director Joe Ahlersmeyer - Vice President of Investor Relations Rachel Wilson - Chief Financial Officer Conference Call Participants Keith Brian Hughes - Truist Securities, Inc., Research Division Keith Chau - MST Financial Services Pty Limited, Research Division Lee Power - JPMorgan Chase & Co, Research Division Peter Steyn - Macquarie Research Philip H.
Investors interested in stocks from the Building Products - Miscellaneous sector have probably already heard of Quanex Building Products (NX) and James Hardie (JHX). But which of these two stocks offers value investors a better bang for their buck right now?
James Hardie (JHX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
The AZEK acquisition is a strategic move, creating a leading exterior/outdoor living platform and unlocking significant revenue and cost synergies for future growth. Deepening partnerships with major U.S. homebuilders and strong ColorPlus® offering ALLIANCE™ program are driving share gains and material conversion in key markets. While R&R market softness remains a risk, JHX's superior growth outlook, margin performance, and ambitious fiber cement penetration targets justify a premium valuation.
Investors looking for stocks in the Building Products - Miscellaneous sector might want to consider either Compagnie de Saint-Gobain - Unsponsored ADR (CODYY) or James Hardie (JHX). But which of these two stocks offers value investors a better bang for their buck right now?
James Hardie Industries plc shares dropped on Wednesday after the building materials manufacturer posted a 17% decline in annual net profit, with cautious guidance adding to investor unease over its proposed $14 billion takeover of US-based AZEK Company. The company reported net profit attributable to shareholders of US$424 million for the 2025 financial year, down from US$510.2 million the prior year, while revenue slipped 1% to US$3.88 billion.